Scoliscore AIS is a saliva-based genetic test to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
Read Axial Biotech’s release about its Scoliscore AIS Prognostic Test.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
